COX-2 Inhibitors Contraindicated For Heart Disease Patients In Europe
This article was originally published in The Pink Sheet Daily
Executive Summary
European Medicines Agency says COX-2 inhibitors should not be used in individuals with ischemic heart disease or stroke and recommends caution when prescribing the drugs for patients with risk factors for heart disease. Agency also adds a hypertension contraindication for Merck’s Arcoxia.
You may also be interested in...
Pfizer Pulls Celebrex's FAP Indication Quickly After Slow Trial Results
The European Medicines Agency issues a formal review, even though the claim had been withdrawn, in order to discourage off-label use.
Pfizer Pulls Celebrex's FAP Indication Quickly After Slow Trial Results
The European Medicines Agency issues a formal review, even though the claim had been withdrawn, in order to discourage off-label use.
NSAID Safety Data Merit No Further Action, EMEA Committee Says
However, the Committee for Medicinal Products for Human Use recommends consistent labeling at the national level.